Source:http://linkedlifedata.com/resource/pubmed/id/17554210
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003402,
umls-concept:C0013227,
umls-concept:C0014442,
umls-concept:C0017262,
umls-concept:C0017337,
umls-concept:C0021666,
umls-concept:C0022173,
umls-concept:C0034693,
umls-concept:C0050078,
umls-concept:C0139905,
umls-concept:C0185117,
umls-concept:C0205054,
umls-concept:C0392747,
umls-concept:C0441889,
umls-concept:C0443172,
umls-concept:C0812215,
umls-concept:C1306673,
umls-concept:C1522492,
umls-concept:C1527148,
umls-concept:C1880266,
umls-concept:C2239176,
umls-concept:C2911684
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-6-7
|
pubmed:abstractText |
This is an extensive study in a defined initiation-promotion hepatocellular carcinoma model of hepatocarcinogenesis (in rats) in which many important marker enzymes and isoenzymes and 8-hydroxydeoxyguanosine formation have been studied together with two very important cellular proliferating genes, insulin-like growth factor II and c-raf.1, known for their role in hepatocellular cancer development. Experiments were carried out on hepatic tissues of male Sprague-Dawley rats. Variations in different enzyme/isoenzyme activities/contents/expression pattern and 8-hydroxydeoxyguanosine-positive cells were studied. Insulin-like growth factor II and c-raf.1 gene expressions were monitored. A direct shift with increase in size and numbers of lesions was found to occur in different experimental groups. In this study, glutathione peroxidase (1.14 and 1.46-fold) and reduced triphosphopyridine nucleotide (TPNH)-cytochrome-c-reductase (1.94 and 2.94-fold) activities, cytochrome b5 (1.57 and 3.28-fold) and P-450 contents (1.45 and 1.22-fold), glutathione content (1.27 and 1.45-fold) and superoxide dismutase and catalase (1.16 and 1.39-fold) activities in group A animals were found to be lower than those in initiation and promotion studies, respectively. 8-Hydroxydeoxyguanosine-positive nuclei count showed that oxidative damage of nuclear DNA enhanced with the progress of the disease. The insulin-like growth factor II expression was found to be predominant in hepatocellular carcinoma and in early preneoplastic lesions. Unlike insulin-like growth factor II, c-raf.1 expression was located in the late basophilic lesions associated with hepatocellular carcinoma. During the various stages of the development of hepatocellular carcinoma, the enzymes played a significant role in metabolizing carcinogens and thereby scavenging various toxic metabolites or free radicals produced. A sequence of cellular changes starting from the appearance of glycogen storage foci to basophilic foci leading to hepatocellular carcinoma via mixed cell foci varied the activity/content or expression pattern of the enzymes and isoenzymes and in 8-hydroxydeoxyguanosine formation. It has been established that c-raf.1-induced signaling pathways activated by insulin-like growth factor II is implicated in the late stage of development of cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/8-hydroxy-2'-deoxyguanosine,
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyguanosine,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose-6-Phosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor II,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-raf
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0959-8278
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
363-71
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17554210-Animals,
pubmed-meshheading:17554210-Antioxidants,
pubmed-meshheading:17554210-Carcinoma, Hepatocellular,
pubmed-meshheading:17554210-Cell Nucleus,
pubmed-meshheading:17554210-Deoxyguanosine,
pubmed-meshheading:17554210-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17554210-Glucose-6-Phosphatase,
pubmed-meshheading:17554210-Glutathione,
pubmed-meshheading:17554210-Insulin-Like Growth Factor II,
pubmed-meshheading:17554210-Isoenzymes,
pubmed-meshheading:17554210-Liver,
pubmed-meshheading:17554210-Male,
pubmed-meshheading:17554210-Metabolic Detoxication, Drug,
pubmed-meshheading:17554210-Precancerous Conditions,
pubmed-meshheading:17554210-Proto-Oncogene Proteins c-raf,
pubmed-meshheading:17554210-Rats,
pubmed-meshheading:17554210-Rats, Sprague-Dawley
|
pubmed:year |
2007
|
pubmed:articleTitle |
Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats.
|
pubmed:affiliation |
Department of Pharmaceutical Technology, Jadavpur University, Kolkata, West Bengal, India. biswajit55@yahoo.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|